- 专利标题: Marker peptide for determining risk of hyperglycemia and use thereof
-
申请号: US14438479申请日: 2013-12-10
-
公开(公告)号: US09970946B2公开(公告)日: 2018-05-15
- 发明人: Chiyoko Uchiyama , Kei Kurita
- 申请人: LION CORPORATION
- 申请人地址: JP Sumida-ku
- 专利权人: LION CORPORATION
- 当前专利权人: LION CORPORATION
- 当前专利权人地址: JP Sumida-ku
- 代理机构: Oblon, McClelland, Maier & Neustadt, L.L.P.
- 优先权: JP2012-278388 20121220
- 国际申请: PCT/JP2013/083118 WO 20131210
- 国际公布: WO2014/097932 WO 20140626
- 主分类号: G01N33/68
- IPC分类号: G01N33/68 ; C07K14/47
摘要:
The object of the present invention is to provide a marker substance capable of determining a risk of hyperglycemia in vivo with high accuracy. The present invention provides the following: a marker peptide for determining the risk of hyperglycemia; an antibody or an aptamer bound to the marker peptide for determining the risk of hyperglycemia; a microarray wherein the antibody or the aptamer to be bound to the marker peptide for determining the risk of hyperglycemia has been immobilized onto a carrier; a method of determining the risk of hyperglycemia wherein an amount or the presence/absence of the marker peptide for determining the risk of hyperglycemia is measured in a biological sample collected from a subject; and a kit for determining the risk of hyperglycemia comprising the antibody or the aptamer, or the microarray.
公开/授权文献
信息查询
IPC分类: